Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma
- 15 March 1997
- Vol. 79 (6) , 1094-1099
- https://doi.org/10.1002/(sici)1097-0142(19970315)79:6<1094::aid-cncr6>3.0.co;2-g
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.Journal of Clinical Oncology, 1995
- Preclinical and clinical aspects of biomodulation of 5-fluorouracilCancer Treatment Reviews, 1994
- Inhibition of dihydropyrimidine dehydrogenase by ?-interferon: experimental data on human tumor cell linesCancer Chemotherapy and Pharmacology, 1994
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Stimulation of 5-fluorouracil metabolic activation by interferon-α in human colon carcinoma cellsBiochemical and Biophysical Research Communications, 1992
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study.Journal of Clinical Oncology, 1989
- High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958